The recent deployment of iotaMotion’s iotaSOFT® Insertion System outside the United States marks a significant step forward in the evolution of cochlear implant technology. This pre-market clinical investigation, now underway at the University Hospital of Zurich under the leadership of Professor Alexander Huber, signals the global expansion of robotic-assisted systems in otologic surgery. As the first international use of iotaSOFT®, this milestone highlights the growing demand for precision tools that enhance the safety, consistency, and effectiveness of cochlear implant procedures, especially as patient expectations for hearing outcomes continue to rise.

The iotaSOFT® system is at the forefront of surgical innovation, offering speed-controlled electrode array insertion guided by real-time electrocochleography (ECochG). This level of control and feedback during implantation allows for improved protection of delicate cochlear structures, which is essential for preserving residual hearing and optimizing post-surgical programming. By linking insertion dynamics with cochlear function through ECochG signals, the system offers valuable insights that can inform future clinical strategies and individualize cochlear implant care. Previously used in over 750 cases in the U.S., its introduction to Europe reflects growing confidence in robotic-assisted technologies for complex and delicate surgical applications.

This international clinical trial not only underscores the technological maturity of iotaMotion’s solution but also represents a turning point for global cochlear implant practices. With plans for broader availability by 2026, iotaMotion is positioning itself as a key player in the worldwide shift toward more intelligent, data-driven surgical systems. The partnership with the University Hospital of Zurich sets a collaborative precedent for future research and clinical integration, ultimately aiming to enhance patient outcomes and reshape standards in hearing restoration.

MedTech Spectrum's Summary

Global Expansion of Innovation: iotaMotion’s iotaSOFT® Insertion System was used for the first time outside the U.S. at the University Hospital of Zurich, marking a significant milestone in the global adoption of robotic-assisted cochlear implant technology.

Advanced Surgical Precision: The system allows speed-controlled electrode insertion with real-time electrocochleography (ECochG), improving cochlear protection and offering valuable data to refine hearing preservation and implant programming.

Future Clinical Impact: This international trial sets the stage for broader availability by 2026 and highlights the growing role of robotic systems in advancing surgical outcomes and global standards in cochlear implant care.